McKesson (NYSE:MCK) Stock: Insider Francisco Fraga Sells 650 Shares

McKesson Corporation (NYSE:MCK) EVP Francisco Fraga sold 650 shares of the stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $1,102.96, for a total value of $716,924.00. Following the completion of the transaction, the executive vice president directly owned 4,414 shares in the company, valued at $4,868,465.44. This represents a 12.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Francisco Fraga also recently made the following trade(s):

• On Wednesday, November 4th, Francisco Fraga sold 600 shares of McKesson stock. The stock was sold at an average price of $1,050.00, for a total value of $630,000.00.
• On Thursday, October 15th, Francisco Fraga sold 800 shares of McKesson stock. The stock was sold at an average price of $995.80, for a total transaction of $796,640.00.

McKesson Trading Down 1.0%

Shares of MCK stock opened at $1,060.79 on Friday. The business’s 50 day moving average is $938.13 and its two-hundred day moving average is $868.12. McKesson Corporation has a 12-month low of $723.68 and a 12-month high of $1,121.50. The company has a market capitalization of $122.48 billion, a P/E ratio of 27.28, a P/E/G ratio of 2.08 and a beta of 0.27.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, topping the consensus estimate of $10.72 by $0.96. The company had revenue of $110.96 billion during the quarter, compared to analyst estimates of $109.90 billion. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. The firm’s revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $9.86 EPS. On average, research analysts predict that McKesson Corporation will post 46.21 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be paid a $0.94 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.67%.

Key Headlines Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson beat fiscal Q2 2027 estimates, reporting adjusted EPS of $11.68 and revenue of about $111 billion, up roughly 7.5% year over year. The company also raised its fiscal 2027 adjusted EPS outlook to $45.60–$46.40, supported by specialty-drug demand, higher prescription volumes and operating gains. MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
• Positive Sentiment: Analyst sentiment has strengthened: UBS raised its price target to $1,250 and maintained a Buy rating, while TD Cowen and Leerink Partners lifted targets to $1,200. Separately, Zacks upgraded MCK to Rank #2 (Buy), citing improving earnings prospects. Zacks upgrades McKesson to Buy
• Neutral Sentiment: EVP Francisco Fraga sold 650 shares under a pre-arranged Rule 10b5-1 plan and retained 4,414 shares. The filing does not explain the purpose of this latest sale; an earlier sale was described as covering tax withholding on vested equity awards. SEC filing
• Negative Sentiment: RBC raised its price target but kept a Sector Perform rating and set a $965 target, below the recent share price. That more cautious view may temper enthusiasm after MCK’s strong run. RBC comments on McKesson’s execution

Institutional Investors Weigh In On McKesson

Hedge funds have recently modified their holdings of the company. Secure Asset Management LLC boosted its position in shares of McKesson by 484.8% during the 2nd quarter. Secure Asset Management LLC now owns 2,123 shares of the company’s stock worth $1,604,000 after purchasing an additional 1,760 shares during the period. BayBridge Capital Group LLC raised its position in McKesson by 268.0% in the second quarter. BayBridge Capital Group LLC now owns 1,943 shares of the company’s stock valued at $1,468,000 after purchasing an additional 1,415 shares during the period. Royal London Asset Management Ltd. raised its position in McKesson by 1.1% in the second quarter. Royal London Asset Management Ltd. now owns 112,241 shares of the company’s stock valued at $84,809,000 after purchasing an additional 1,216 shares during the period. Benchmark Investment Advisors LLC purchased a new stake in McKesson in the second quarter valued at approximately $441,000. Finally, Summit Global Investments acquired a new position in McKesson during the second quarter worth $1,159,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

MCK has been the topic of several research reports. Bank of America raised their target price on McKesson from $950.00 to $1,050.00 in a research report on Thursday, August 6th. Wells Fargo & Company increased their price objective on McKesson from $812.00 to $933.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 11th. Argus raised their price objective on McKesson from $850.00 to $970.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. UBS Group lifted their target price on shares of McKesson from $1,200.00 to $1,250.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, Barclays upped their target price on shares of McKesson from $925.00 to $1,000.00 and gave the stock an “overweight” rating in a report on Wednesday, August 19th. Fifteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $1,026.18.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers.

The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care.

Founded in 1833, McKesson serves customers primarily in the United States and Canada.